SCHEMBL5294302

SCHEMBL5294302

Fc1ccc(-c2ccccc2)c(F)c1N1CCNCC1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR7 P34969 7/20 0.53
HTR6 P50406 6/20 0.53
HTR1A P08908 6/20 0.53
HTR2A P28223 1/20 0.53
HTR5A P47898 1/20 0.53
HTR3A P46098 3/20 0.44
ALDH1A1 P00352 1/20 0.44
LMNA P02545 1/20 0.44
HTR3E A5X5Y0 1/20 0.44
HTR3B O95264 1/20 0.44
ADRB1 P08588 1/20 0.44
HTR3D Q70Z44 1/20 0.44
HTR3C Q8WXA8 1/20 0.44
SIGMAR1 Q99720 1/20 0.44
HTR2B P41595 3/20 0.40
HTR2C P28335 1/20 0.40
CSNK1D P48730 1/20 0.40
MAPK11 Q15759 1/20 0.40
MAPK14 Q16539 1/20 0.40
CETP P11597 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5305271 0.76 HTR2C (0.40) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL4914927 0.76 HTR7 (0.73) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL6650883 0.75 HTR7 (0.59) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL4909484 0.75 HTR7 (0.59) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL746343 0.74 ALDH1A1 (0.54) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL5366514 0.71 HTR6 (0.56) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL4909469 0.70 HTR7 (0.58) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL30146694 0.70 HTR7 (0.58) HTR7HTR6HTR1AHTR2AHTR5A
SCHEMBL28618211 0.70 KDM4E (0.41) ALDH1A1LMNA
SCHEMBL3759275 0.69 HTR7 (1.00) HTR7HTR6HTR1AHTR2AHTR5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1828156-A2 N-BIARYL AND N-ARYLHETEROARYL PIPERAZINE DERIVATIVES AS MODULATORS OF THE 5HT2C RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO Arena Pharmaceuticals, Inc. (US) 2007-09-05 EP claimed
WO-2006065600-A2 N-BIARYL AND N-ARYLHETEROARYL PIPERAZINE DERIVATIVES AS MODULATORS OF THE 5HT2C RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO ARENA PHARMACEUTICALS, INC. (US) 2006-06-22 WO claimed